This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 6, No 10 (2017): October

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol

Authors of this article:

Lisa M Hess1 Author Orcid Image ;   David M Kern2 Author Orcid Image ;   Gebra Cuyun Carter1 Author Orcid Image ;   Liya Wang2 Author Orcid Image ;   Katherine Winfree1 Author Orcid Image ;   Zhanglin Lin Cui3 Author Orcid Image ;   Angelina Sontag1 Author Orcid Image ;   Ana B Oton1 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Journals

  1. Deverka P, Douglas M, Phillips K. Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions. Value in Health 2020;23(5):540 View
  2. Hammond E, Tummala R, Berglind A, Syed F, Wang X, Desta B, Nab H. Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature. BMJ Open 2020;10(9):e036563 View
  3. Grabner M, Molife C, Wang L, Winfree K, Cui Z, Cuyun Carter G, Hess L. Data Integration to Improve Real-world Health Outcomes Research for Non–Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR Cancer 2021;7(2):e23161 View
  4. Chouaïd C, Grumberg V, Batisse A, Corre R, Giaj Levra M, Gaudin A, Prodel M, Lortet-Tieulent J, Assié J, Cotté F. Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab. JCO Clinical Cancer Informatics 2022;(6) View